Literature DB >> 11238713

Modulation of the neuronal dopamine transporter activity by the metabotropic glutamate receptor mGluR5 in rat striatal synaptosomes through phosphorylation mediated processes.

G Page1, M Peeters, M Najimi, J M Maloteaux, E Hermans.   

Abstract

There is considerable evidence that the activity of the neuronal dopamine transporter (DAT) is dynamically regulated and a putative implication of its phosphorylation in this process has been proposed. However, there is little information available regarding the nature of physiological stimuli that contribute to the endogenous control of the DAT function. Based on the close relationship between glutamatergic and dopaminergic systems in the striatum, we investigated the modulation of the DAT activity by metabotropic glutamate receptors (mGluRs). Short-term incubations of rat striatal synaptosomes with micromolar concentrations of the group I mGluR selective agonist (S)-3,5-dihydroxyphenylglycine were found to significantly decrease the DAT capacity and efficiency. This alteration was completely prevented by a highly selective mGluR5 antagonist, 2-methyl-6-(phenylethynyl)pyridine hydrochloride (MPEP). The effect of (S)-3,5-dihydroxyphenylglycine was also inhibited by staurosporine and by selective inhibitors of protein kinase C and calcium calmodulin-dependent protein kinase II. Co-application of okadaic acid prolonged the transient effect of the agonist, supporting a critical role for phosphorylation in the modulation of the DAT activity by mGluRs. In conclusion, we propose that striatal mGluR5 contribute to the control of the DAT activity through concomitant activation of both protein kinase C and calcium calmodulin-dependent protein kinase II.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11238713     DOI: 10.1046/j.1471-4159.2001.00179.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  16 in total

1.  Neuroimaging and physiological evidence for involvement of glutamatergic transmission in regulation of the striatal dopaminergic system.

Authors:  Masaki Tokunaga; Nicholas Seneca; Ryong-Moon Shin; Jun Maeda; Shigeru Obayashi; Takashi Okauchi; Yuji Nagai; Ming-Rong Zhang; Ryuji Nakao; Hiroshi Ito; Robert B Innis; Christer Halldin; Kazutoshi Suzuki; Makoto Higuchi; Tetsuya Suhara
Journal:  J Neurosci       Date:  2009-02-11       Impact factor: 6.167

2.  Protein kinase A directly phosphorylates metabotropic glutamate receptor 5 to modulate its function.

Authors:  Ken Uematsu; Myriam Heiman; Marina Zelenina; Júlio Padovan; Brian T Chait; Anita Aperia; Akinori Nishi; Paul Greengard
Journal:  J Neurochem       Date:  2015-03-04       Impact factor: 5.372

3.  mGlu5 in GABAergic neurons modulates spontaneous and psychostimulant-induced locomotor activity.

Authors:  Chia-Shan Wu; Christopher P Jew; Hao Sun; Carlos J Ballester Rosado; Hui-Chen Lu
Journal:  Psychopharmacology (Berl)       Date:  2019-10-24       Impact factor: 4.530

Review 4.  Direct dopamine terminal regulation by local striatal microcircuitry.

Authors:  Suzanne O Nolan; Jennifer E Zachry; Amy R Johnson; Lillian J Brady; Cody A Siciliano; Erin S Calipari
Journal:  J Neurochem       Date:  2020-06-19       Impact factor: 5.372

5.  Methylphenidate Decreases ATP Levels and Impairs Glutamate Uptake and Na+,K+-ATPase Activity in Juvenile Rat Hippocampus.

Authors:  Felipe Schmitz; Paula Pierozan; André F Rodrigues; Helena Biasibetti; Mateus Grings; Bruna Zanotto; Daniella M Coelho; Carmen R Vargas; Guilhian Leipnitz; Angela T S Wyse
Journal:  Mol Neurobiol       Date:  2016-11-14       Impact factor: 5.590

6.  The antidepressant-like action of mGlu5 receptor antagonist, MTEP, in the tail suspension test in mice is serotonin dependent.

Authors:  Agnieszka Pałucha-Poniewiera; Piotr Brański; Joanna M Wierońska; Katarzyna Stachowicz; Anna Sławińska; Andrzej Pilc
Journal:  Psychopharmacology (Berl)       Date:  2014-01       Impact factor: 4.530

Review 7.  Kinase-dependent Regulation of Monoamine Neurotransmitter Transporters.

Authors:  Daniel P Bermingham; Randy D Blakely
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

8.  Inhibition of mitochondrial respiratory chain in the brain of adult rats after acute and chronic administration of methylphenidate.

Authors:  Ana O Fagundes; Giselli Scaini; Patricia M Santos; Monique U Sachet; Nayara M Bernhardt; Gislaine T Rezin; Samira S Valvassori; Patrícia F Schuck; João Quevedo; Emilio L Streck
Journal:  Neurochem Res       Date:  2009-09-24       Impact factor: 3.996

9.  Inhibition of acetylcholinesterase activity in brain and behavioral analysis in adult rats after chronic administration of fenproporex.

Authors:  Gislaine T Rezin; Giselli Scaini; Gabriela K Ferreira; Mariane R Cardoso; Cinara L Gonçalves; Larissa S Constantino; Pedro F Deroza; Fernando V Ghedim; Samira S Valvassori; Wilson R Resende; João Quevedo; Alexandra I Zugno; Emilio L Streck
Journal:  Metab Brain Dis       Date:  2012-07-27       Impact factor: 3.584

10.  Salvinorin A regulates dopamine transporter function via a kappa opioid receptor and ERK1/2-dependent mechanism.

Authors:  Bronwyn Kivell; Zeljko Uzelac; Santhanalakshmi Sundaramurthy; Jeyaganesh Rajamanickam; Amy Ewald; Vladimir Chefer; Vanaja Jaligam; Elizabeth Bolan; Bridget Simonson; Balasubramaniam Annamalai; Padmanabhan Mannangatti; Thomas E Prisinzano; Ivone Gomes; Lakshmi A Devi; Lankupalle D Jayanthi; Harald H Sitte; Sammanda Ramamoorthy; Toni S Shippenberg
Journal:  Neuropharmacology       Date:  2014-08-10       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.